ARTICLE

IRRITABLE BOWEL SYNDROME IN WESTERN AND NONWESTERN POPULATIONS PREVALENCE PSYCHOLOGICAL COMORBIDITIES QUALITY OF LIFE AND ROLE OF NUTRITION

  1. HOME
  2. ARTICLE

08 Pages : 64-76

http://dx.doi.org/10.31703/giidr.2024(IX-III).08      10.31703/giidr.2024(IX-III).08      Published : Sep 2024

Irritable Bowel Syndrome in Western and Non-Western Populations: Prevalence, Psychological Comorbidities, Quality of Life and Role of Nutrition

Abstract

    Irritable Bowel Syndrome (IBS) is a chronic gastrointestinal disorder with various subtypes (IBS-C, IBS-D, IBS-M, IBS-U), affecting both Western and non-Western populations. Prevalence varies globally, influenced by diagnostic criteria, survey methods, and cultural factors. Women are more commonly affected, especially by IBS-C, but regional and ethnic differences exist. Psychological comorbidities, including anxiety and depression, worsen symptoms and quality of life. Dietary interventions, such as gluten elimination and low FODMAP diets, help manage symptoms, but challenges remain, particularly in non-Western countries due to limited knowledge. This essay critiques the Western-centric Rome IV diagnostic criteria, advocating for a broader approach that includes psychological and gastrointestinal factors in IBS diagnosis and management.

    Irritable Bowel Syndrome, Prevalence, Psychological Comorbidities, FODMAP Diet, Rome IV Criteria

    (1) Aroob Aslam
    MS Scholar, Institute of Administrative Sciences, University of the Punjab, Lahore, Punjab, Pakistan.
Fulltext PDF

References

  • Abid, S., Rehman, H., Awan, S., Artani, A., & Siddiqui, I. (2022). Epidemiology of functional gastrointestina

  • Aljammaz, K., Alrashed, A., & Alzwaid, A. (2020). Irritable bowel syndrome: Epidemiology and risk factors

  • Bai, T., Xia, J., Jiang, Y., Cao, H., Zhao, Y., Zhang, L., Wang, H., Song, J., & Hou, X. (2016). Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross

  • Bhopal, R. S., Cezard, G., Bansal, N., Ward, H. J. T., & Bhala, N. (2014). Ethnic variations in five lower gastrointestinal diseases: Scottish Health and Ethnicity Linkage Study. BMJ Open, 4(10), e006120.

  • Biesiekierski, J. R., Newnham, E. D., Irving, P. M., Barrett, J. S., Haines, M., Doecke, J. D., Shepherd, S. J., Muir, J. G., & Gibson, P. R. (2011). Gluten causes gastrointestinal symptoms in subjects without Celiac disease: a Double-Blind Randomized Placebo-Controlled trial. The A

  • Black, C. J., & Ford, A. C. (2020). Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nature Reviews Gastroenterology & Hepatology, 17(8), 473–486.

  • Bortolotti, M., & Porta, S. (2011). Effect of red pepper on symptoms of irritable bowel Syndrome: preliminary study. Digestive Diseases and Sciences, 56(11), 3288–3295.

  • Cañón, M. (2016). Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic survey. Annals of Gastroenterology.

  • Card, T., Canavan, C., & West, J. (2014). The epidemiology of irritable bowel syndrome. Clinical Epidemiology, 71.

  • Chatila, R., Merhi, M., Hariri, E., Sabbah, N., & Deeb, M. E. (2017b). Irritable bowel syndrome: prevalence, risk factors in an adult Lebanese population. BMC Gastroenterology, 17(1).

  • Chuah, K., & Mahadeva, S. (2018). Cultural factors influencing functional gastrointestinal disorders in the East. Journal of Neurogastroenterology and Motility, 24(4), 536–543.

  • Corsetti, M., Tack, J., Attara,

  • Creed, F. (2019). Review article: the incidence and risk factors for irritable bowel syndrome in population‐

  • Drossman, D. A. (2016). Functional Gastrointestinal Disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology, 150(6), 1262-1279.e2.

  • El-Salhy, M., Patcharatrakul, T., Hatlebakk, J. G., Hausken, T., Gilja, O. H., & Gonlachanvit, S. (2017). Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome. Scandinavian Journal of Gas

  • Frändemark, Å., Törnblom, H., Jakobsson, S., & Simrén, M. (2018). Work productivity and activity impairment in Irritable bowel Syndrome (IBS): a multifaceted problem. The American Journal of Gastroenterology, 113(10), 1540–1549.

  • Ghosh, D. K., Nath, M., Biswas, A., Khondakar, M. F. A., & Ghosh, C. K. (2022). Prevalence of irritable bowel syndrome: A comparison between rural and urban settings in Bangladesh. Bangladesh Medical Research Council Bulletin, 47(1), 7

  • Ghoshal, U. C., & Singh, R. (2016). Frequency and risk factors of functional gastro‐

  • Goodoory, V. C., Mikocka-Walus, A., Yiannakou, Y., Houghton, L. A., Black, C. J., & Ford, A. C. (2021). Impact of psychological comorbidity on the prognosis of irritable bowel syndrome. The American Journal of Gastroenterology, 116(7),

  • Goodoory, V. C., Ng, C. E., Black, C. J., & Ford, A. C. (2022). Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 55<

  • Grover, M., Kolla, B. P., Pamarthy, R., Mansukhani, M. P., Breen-Lyles, M., He, J., & Merikangas, K. R. (2021). Psychological, physical, and sleep comorbidities and functional impairment in irritable bowel syndrome: Results from a national survey of

  • Guadagnoli, L., Mutlu, E. A., Doerfler, B., Ibrahim, A., Brenner, D., & Taft, T. H. (2019). Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome. Quality of Life Research, 28(8), 2195–22

  • Gwee, K. A., Gonlachanvit, S., Ghoshal, U. C., Chua, A. S. B., Miwa, H., Wu, J., Bak, Y., Lee, O. Y., Lu, C., Park, H., Chen, M., Syam, A. F., Abraham, P., Sollano, J., Chang, C., Suzuki, H., Fang, X., Fukudo, S., Choi, M., . . . Hongo, M. (2019). Secon

  • Gwee, K., Ghoshal, U. C., & Chen, M. (2017). Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management. Journal of Gastroenterology and Hepatology, 33(1), 99–110.

  • Hekmatdoost, A., Jalili, M., Vahedi, H., & Poustchi, H. (2019). Effects of Vitamin D supplementation in patients with irritable bowel syndrome: A randomized, double-blind, placebo-controlled clinical trial. International Journal of Preventive Med

  • Hewawasam, S. P., Iacovou, M., Muir, J. G., & Gibson, P. R. (2017). Dietary practices and FODMAPs in South Asia: Applicability of the low FODMAP diet to patients with irritable bowel syndrome. Journal of Gastroenterology and Hepatology, 33

  • Hujoel, I. A. (2020). Nutritional status in irritable bowel syndrome: A North American population‐

  • Kanazawa, M., Miwa, H., Nakagawa, A., Kosako, M., Akiho, H., & Fukudo, S. (2016). Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan. BioPsych

  • Keshteli, A. H., Dehestani, B., Daghaghzadeh, H., & Adibi, P. (2015). Epidemiological features of irritable bowel syndrome and its subtypes among Iranian adults. Annals of Gastroenterology, 28(2), 253–258.

  • Koloski, N. A., Jones, M., & Talley, N. J. (2016). Evidence that independent gut‐

  • Koloski, N. A., Jones, M., Kalantar, J., Weltman, M., Zaguirre, J., & Talley, N. J. (2012). The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut, 61(9), 1284

  • Lacy, B. E., Everhart, K. K., Weiser, K. T., DeLee, R., Strobel, S., Siegel, C., & Crowell, M. D. (2012). IBS patients’ willingness to take risks with medications. The American Journal of Gastroenterology, 107(6), 804–809.

  • Latif, A., Memon, F. A., & Asad, M. (2020). Irritable bowel syndrome in a population of a developing country: Prevalence and association. Cureus.

  • Liu, H., Huang, L., Li, L., Lu, T., Liang, H., & Liu, C. (2023). HLA-DQ and alcohol in the pathogenesis of irritable bowel syndrome in college students: a case–control study. Scientific Reports, 13(1).

  • Lovell, R. M., & Ford, A. C. (2012). Global prevalence of and risk factors for Irritable bowel Syndrome: A Meta-analysis. Clinical Gastroenterology and Hepatology, 10(7), 712-721.e4.

  • Mayer, E. A., Ryu, H. J., & Bhatt, R. R. (2023). The neurobiology of irritable bowel syndrome. Molecular Psychiatry, 28(4), 1451–1465.

  • Mohseni, F., Agah, S., Ebrahimi-Daryani, N., Taher, M., Nattagh-Eshtivani, E., Karimi, S., Rastgoo, S., Bourbour, F., & Hekmatdoost, A. (2021). The effect of low FODMAP diet with and without gluten on irritable bowel syndrome: A double blind, placeb

  • Nagasako, C. K., Montes, C. G., Lorena, S. L. S., & Mesquita, M. A. (2015). Irritable bowel syndrome subtypes: Clinical and psychological features, body mass index and comorbidities. Revista Española De Enfermedades Digestivas, 108.

  • Nakov, R., Dimitrova-Yurukova, D., Snegarova, V., Uzunova, M., Lyutakov, I., Ivanova, M., Madzharova, K., Valkov, H., Hristova, R., Ivanov, K., Kosturkov, I., Valcheva, G., Nakov, N., & Nakov, V. (2020). Prevalence of Irritable Bowel Syndrome, Funct

  • Nybacka, S., Störsrud, S., Lindqvist, H. M., Törnblom, H., Simrén, M., & Winkvist, A. (2020). Habitual FODMAP Intake in Relation to Symptom Severity and Pattern in Patients with Irritable Bowel Syndrome. Nutrients, 13(1), 27.

  • Oka, P., Parr, H., Barberio, B., Black, C. J., Savarino, E. V., & Ford, A. C. (2020). Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.

  • Okami, Y., Kato, T., Nin, G., Harada, K., Aoi, W., Wada, S., Higashi, A., Okuyama, Y., Takakuwa, S., Ichikawa, H., Kanazawa, M., & Fukudo, S. (2011). Lifestyle and psychological factors related to irritable bowel syndrome in nursing and medical scho

  • Palsson, O. S., Whitehead, W., Törnblom, H., Sperber, A. D., & Simren, M. (2020). Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom. Gastroenterology, 158(5), 1262-1273.e

  • Parker, C. H., Naliboff, B. D., Shih, W., Presson, A. P., Kilpatrick, L., Gupta, A., Liu, C., Keefer, L. A., Sauk, J. S., Hirten, R., Sands, B. E., & Chang, L. (2020). The role of resilience in irritable bowel syndrome, other chronic gastrointestina

  • Person, H., & Keefer, L. (2020). Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 107, 110209.

  • Quach, D. T., Vu, K. T., & Van Vu, K. (2021). Prevalence, clinical characteristics, and management of irritable bowel syndrome in Vietnam: A scoping review. JGH Open, 5(11), 1227–1235.

  • Qumseya, B. J., Tayem, Y., Almansa, C., Dasa, O. Y., Hamadneh, M. K., Al-Sharif, A. F., Hmidat, A. M., Abu-Limon, I. M., Nahhal, K. W., Alassas, K., DeVault, K., Wallace, M. B., & Houghton, L. A. (2014). Irritable Bowel Syndrome in Middle-Aged and E

  • Rahman, M. M., Mahadeva, S., & Ghoshal, U. C. (2017). Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review. World Journal of Gastroenterology, 23(37), 6788–6801.

  • Safaee, A., Moghimi-Dehkordi, B., Pourhoseingholi, M. A., Vahedi, M., Habibi, M., Pourhoseingholi, A., & Ghafarnejad, F. (2011). Bloating in irritable bowel syndrome. Gastroenterology and Hepatology from Bed to Bench, 4(2), 86–90.

  • Satake, R., Sugawara, N., Sato, K., Takahashi, I., Nakaji, S., Yasui-Furukori, N., & Fukuda, S. (2015). Prevalence and predictive factors of irritable bowel syndrome in a community-dwelling population in Japan. Internal Medicine, 54(24

  • Shah, S. L., Janisch, N. H., Crowell, M., & Lacy, B. E. (2020). Patients with irritable bowel syndrome are willing to take substantial medication risks for symptom relief. Clinical Gastroenterology and Hepatology, 19(1), 80–86.

  • Shahbazkhani, B., Sadeghi, A., Malekzadeh, R., Khatavi, F., Etemadi, M., Kalantri, E., Rostami-Nejad, M., & Rostami, K. (2015). Non-Celiac gluten sensitivity has narrowed the spectrum of irritable bowel syndrome: a Double-Blind randomized Placebo-Co

  • Singh, V., Nagaonkar, S., Kangule, D., & Sadhanala, S. (2018). A study of prevalence and determinants of irritable bowel syndrome in an urban slum community in Mumbai. Journal of Datta Meghe Institute of Medical Sciences Unive

  • Skodje, G. I., Sarna, V. K., Minelle, I. H., Rolfsen, K. L., Muir, J. G., Gibson, P. R., Veierød, M. B., Henriksen, C., & Lundin, K. E. (2017). Fructan, rather than gluten, induces symptoms in patients with Self-Reported Non-Celiac gluten sensitivit

  • Sperber, A. D., Bangdiwala, S. I., Drossman, D. A., Ghoshal, U. C., Simren, M., Tack, J., Whitehead, W. E., Dumitrascu, D. L., Fang, X., Fukudo, S., Kellow, J., Okeke, E., Quigley, E. M., Schmulson, M., Whorwell, P., Archampong, T., Adibi, P., Andresen,

  • Sperber, A. D., Dumitrascu, D., Fukudo, S., Gerson, C., Ghoshal, U. C., Gwee, K. A., Hungin, A. P. S., Kang, J., Minhu, C., Schmulson, M., Bolotin, A., Friger, M., Freud, T., & Whitehead, W. (2016). The global prevalence of IBS in adults remains elu

  • Sturkenboom, R., Keszthelyi, D., Masclee, A. A., & Essers, B. A. (2022). Discrete Choice experiment reveals strong preference for dietary treatment among patients with irritable bowel syndrome. Clinical Gastroenterology and Hepatology, 20<

  • Takeoka, A., Kimura, T., Hara, S., Hamaguchi, T., Fukudo, S., & Tayama, J. (2023). Prevalence of irritable bowel syndrome in Japan, China, and South Korea: an international cross-sectional study. Journal of Neurogastroenterology and Motility,

  • Varjú, P., Gede, N., Szakács, Z., Hegyi, P., Cazacu, I. M., Pécsi, D., Fábián, A., Szepes, Z., Vincze, Á., Tenk, J., Balaskó, M., Rumbus, Z., Garami, A., Csupor, D., & Czimmer, J. (2018). Lactose intolerance but not lactose maldigestion is more freq

  • Vincenzi, M., Del Ciondolo, I., Pasquini, E., Gennai, K., & Paolini, B. (2017). Effects of a low FODMAP diet and specific carbohydrate diet on symptoms and nutritional adequacy of patients with irritable bowel syndrome: Preliminary results of a sing

  • Wang, J., Yang, P., Zhang, L., & Hou, X. (2021). A Low-FODMAP diet improves the global symptoms and bowel habits of adult IBS patients: A Systematic Review and Meta-Analysis. Frontiers in Nutrition, 8.

  • Weerts, Z. Z. R. M., Vork, L., Mujagic, Z., Keszthelyi, D., Hesselink, M. a. M., Kruimel, J., Leue, C., Muris, J. W., Jonkers, D. M. a. E., & Masclee, A. a. M. (2019). Reduction in IBS symptom severity is not paralleled by improvement in quality of

  • Xiong, L., Gong, X., Siah, K. T., Pratap, N., Ghoshal, U. C., Abdullah, M., Syam, A. F., Bak, Y., Choi, M., Lu, C., Gonlachanvit, S., Chua, A. S. B., Chong, K., Ricaforte

  • Zamani, M., Alizadeh‐Tabari, S., & Zamani, V. (2019). Systematic review with met

  • Zanwar, V. G., Pawar, S. V., Gambhire, P. A., Jain, S. S., Surude, R. G., Shah, V. B., Contractor, Q. Q., & Rathi, P. M. (2016). Symptomatic improvement with gluten restriction in irritable bowel syndrome: a prospective, randomized, double blinded p

Cite this article

APA

    APA : Aslam, A. (2024). Irritable Bowel Syndrome in Western and Non-Western Populations: Prevalence, Psychological Comorbidities, Quality of Life and Role of Nutrition. Global Immunological & Infectious Diseases Review, IX(III), 64-76. https://doi.org/10.31703/giidr.2024(IX-III).08

CHICAGO

    CHICAGO : Aslam, Aroob. 2024. "Irritable Bowel Syndrome in Western and Non-Western Populations: Prevalence, Psychological Comorbidities, Quality of Life and Role of Nutrition." Global Immunological & Infectious Diseases Review, IX (III): 64-76 doi: 10.31703/giidr.2024(IX-III).08

HARVARD

    HARVARD : ASLAM, A. 2024. Irritable Bowel Syndrome in Western and Non-Western Populations: Prevalence, Psychological Comorbidities, Quality of Life and Role of Nutrition. Global Immunological & Infectious Diseases Review, IX, 64-76.

MHRA

    MHRA : Aslam, Aroob. 2024. "Irritable Bowel Syndrome in Western and Non-Western Populations: Prevalence, Psychological Comorbidities, Quality of Life and Role of Nutrition." Global Immunological & Infectious Diseases Review, IX: 64-76

MLA

    MLA : Aslam, Aroob. "Irritable Bowel Syndrome in Western and Non-Western Populations: Prevalence, Psychological Comorbidities, Quality of Life and Role of Nutrition." Global Immunological & Infectious Diseases Review, IX.III (2024): 64-76 Print.

OXFORD

    OXFORD : Aslam, Aroob (2024), "Irritable Bowel Syndrome in Western and Non-Western Populations: Prevalence, Psychological Comorbidities, Quality of Life and Role of Nutrition", Global Immunological & Infectious Diseases Review, IX (III), 64-76

TURABIAN

    TURABIAN : Aslam, Aroob. "Irritable Bowel Syndrome in Western and Non-Western Populations: Prevalence, Psychological Comorbidities, Quality of Life and Role of Nutrition." Global Immunological & Infectious Diseases Review IX, no. III (2024): 64-76. https://doi.org/10.31703/giidr.2024(IX-III).08